Typically, tirzepatide is superior for glucose-lowering and for weight loss, reinforces Dr
Retatrutide is a triple receptor agonist acting on GLP-1, GIP, and glucagon receptors, distinguishing it from semaglutide and tirzepatide
This action complements the GLP-1 effects and provides additional metabolic benefits, particularly in individuals with insulin resistance or type 2 diabetes
Another point worth mentioning here is that the Mayo Clinic (you know, the medical center) was one of Pendulums early investors
If necessary, the dose can be further increased to 1 mg once a week after a minimum of four weeks on the 0.5 mg dose
Why Its GLP-1 Friendly: Lower-carb, easier on digestion, and perfect for preventing post-meal sluggishness